Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development.
Quick Facts
What This Study Found
Key Numbers
How They Did This
Why This Research Matters
What This Study Doesn't Tell Us
Trust & Context
- Original Title:
- Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development.
- Published In:
- Journal of medicinal chemistry, 66(14), 9401-9417 (2023)
- Authors:
- Guerlavais, Vincent, Sawyer, Tomi K, Carvajal, Luis, Chang, Yong S, Graves, Bradford, Ren, Jian-Guo, Sutton, David, Olson, Karen A, Packman, Kathryn, Darlak, Krzysztof, Elkin, Carl, Feyfant, Eric, Kesavan, Kamala, Gangurde, Pranoti, Vassilev, Lyubomir T, Nash, Huw M, Vukovic, Vojislav, Aivado, Manuel, Annis, D Allen
- Database ID:
- RPEP-06925
Evidence Hierarchy
Read More on RethinkPeptides
Related articles coming soon.
Cite This Study
https://rethinkpeptides.com/research/RPEP-06925APA
Guerlavais, Vincent; Sawyer, Tomi K; Carvajal, Luis; Chang, Yong S; Graves, Bradford; Ren, Jian-Guo; Sutton, David; Olson, Karen A; Packman, Kathryn; Darlak, Krzysztof; Elkin, Carl; Feyfant, Eric; Kesavan, Kamala; Gangurde, Pranoti; Vassilev, Lyubomir T; Nash, Huw M; Vukovic, Vojislav; Aivado, Manuel; Annis, D Allen. (2023). Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development.. Journal of medicinal chemistry, 66(14), 9401-9417. https://doi.org/10.1021/acs.jmedchem.3c00623
MLA
Guerlavais, Vincent, et al. "Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permeating, Stabilized α-Helical Peptide in Clinical Development.." Journal of medicinal chemistry, 2023. https://doi.org/10.1021/acs.jmedchem.3c00623
RethinkPeptides
RethinkPeptides Research Database. "Discovery of Sulanemadlin (ALRN-6924), the First Cell-Permea..." RPEP-06925. Retrieved from https://rethinkpeptides.com/research/guerlavais-2023-discovery-of-sulanemadlin-alrn6924
Access the Original Study
Study data sourced from PubMed, a service of the U.S. National Library of Medicine, National Institutes of Health.
This study breakdown was produced by the RethinkPeptides research team. We analyze and report published research findings without making health recommendations. All interpretations are based solely on the published abstract and study data.